Dishman Carbogen Amcis: Insider Trading Window Closes April 1

OTHER
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Dishman Carbogen Amcis: Insider Trading Window Closes April 1
Overview

Dishman Carbogen Amcis Limited will shut its trading window for directors, designated persons, and their immediate relatives from April 1, 2026. This temporary closure, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015, will remain in effect until 48 hours after the announcement of the company's audited financial results for the quarter and year ending March 31, 2026. The measure aims to prevent potential misuse of Unpublished Price Sensitive Information (UPSI) during the financial results disclosure period.

Dishman Carbogen Amcis Limited has announced the closure of its trading window for directors, designated persons, and their immediate relatives. This temporary measure will begin on April 1, 2026.

The window will reopen 48 hours after the company publishes its audited financial results for the quarter and the full financial year ending March 31, 2026.

This action is a standard compliance step under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Its primary purpose is to prevent the misuse of Unpublished Price Sensitive Information (UPSI) by individuals before such information is made public. This practice helps maintain fair and transparent markets.

Impact on Insiders

During this closure period, directors, designated employees, and their close relatives are prohibited from buying or selling shares of Dishman Carbogen Amcis. This restriction ensures that no one can trade on information that is not yet available to the general investing public, thus upholding market integrity. For ordinary investors, this is a routine procedural announcement.

Company Background

Dishman Carbogen Amcis Ltd is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical sector. It provides a range of services including API development and manufacturing.

Industry Standard

Closing trading windows around financial result announcements is a common governance practice for listed companies in India. Major pharmaceutical and API manufacturers like Sun Pharmaceutical Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, and Cipla Ltd also implement similar closures to adhere to regulatory requirements and ensure fair trading.

Compliance

The company has affirmed its adherence to SEBI's insider trading regulations. No specific risks related to insider trading violations have been highlighted in this announcement or recent disclosures.

What to Watch Next

Investors should monitor the date when Dishman Carbogen Amcis releases its audited financial results for the quarter and year ending March 31, 2026. The public announcement of these results will lead to the trading window reopening 48 hours later.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.